EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure

Małgorzata Małek-Elikowska, Andrzej Szyszka, Julita Fedorowicz, Cyntia Szymańska-Łyczkowska, Rafał Dankowski, Artur Baszko

Polski Merkuriusz Lekarski · 01.04.2026 · 54 (2) · 105

DOI: 10.36740/merkur202602103 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Polski Merkuriusz Lekarski, online erschienen am 01.04.2026. Verfasst von Małgorzata Małek-Elikowska und 5 weiteren Autor:innen. Beteiligte Einrichtung: 2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND. Hauptthemen laut MEDLINE: Furosemide, Heart Failure, Length of Stay, Sulfonamides. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the impact of the initial choice between intravenous furosemide and torsemide on mortality outcomes and duration of hospital stay. Materials and Methods: The prospective, open-label, comparative study included 68 adult patients hospitalized with acute heart failure (AHF). Furosemide was administered to 35 patients (51.5%) and torsemide to 33 patients (48.5%) during the first 48 hours after admission. Diuretic dosing was titrated according to urinary sodium concentration. After the initial 48 hours, further diuretic therapy was administered at the discretion of the attending physician. The primary endpoint was all-cause mortality, and the secondary endpoints were length of hospital stay and in-hospital mortality.

Results

All-cause mortality was 51.4% in patients treated with furosemide and 42.4% in those treated with torsemide (p=0.478). The median survival time was 633 days (95% CI 178-1,259) in the furosemide group and 1,093 days (95% CI 541-1,239) in the torsemide group, with no statistically significant difference in survival between the two treatment groups (p=0.44). No in-hospital deaths occurred in the torsemide group, whereas four in-hospital deaths (11.4%) were observed in the furosemide group (p=0.115). The mean length of hospital stay was 12}7 days in both groups (p=0.551).

Conclusions

Both furosemide and torsemide showed no statistically significant differences in all-cause mortality, in-hospital mortality, and length of hospital stay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurosemideHeart FailureLength of StaySulfonamidesDiureticsHumansTorsemideFemaleAgedProspective StudiesMaleAcute DiseaseAged, 80 and overHospital MortalityMiddle Aged

Stichwörter der Autor:innen

Intravenous furosemide and torsemideacute heart failureall-cause mortalitylength of hospital stay

Substanzen

FurosemideTorsemideSulfonamidesDiuretics

Autor:innen und Institutionen

  • 2ND DEPARTMENT OF CARDIOLOGY, POZNAN UNIVERSITY OF MEDICAL SCIENCES, POZNAN, POLAND.

Zitieren

APA

Małek-Elikowska, M., Szyszka, A., Fedorowicz, J., Szymańska-Łyczkowska, C., Dankowski, R., & Baszko, A. (2026). Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure. Polski Merkuriusz Lekarski, 54(2), 105. https://doi.org/10.36740/merkur202602103

Vancouver

Małek-Elikowska M, Szyszka A, Fedorowicz J, Szymańska-Łyczkowska C, Dankowski R, Baszko A. Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure. Polski Merkuriusz Lekarski. 2026;54(2):105. doi:10.36740/merkur202602103

BibTeX
@article{MaekElikowska2026,
  author = {Małek-Elikowska, Małgorzata and Szyszka, Andrzej and Fedorowicz, Julita and Szymańska-Łyczkowska, Cyntia and Dankowski, Rafał and Baszko, Artur},
  title = {Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure},
  journal = {Polski Merkuriusz Lekarski},
  year = {2026},
  volume = {54},
  number = {2},
  pages = {105},
  doi = {10.36740/merkur202602103}
}
Kostenlos starten →